Connplex Cinemas is India’s fastest-growing chain of Smart Luxury Cinemas, bringing together cutting-edge technology, stylish comfort, and affordable pricing. With 300+ screens across the country, over 30 franchises, and a legacy in film marketing and distribution since 2009, the brand has redefined movie-going for urban and semi-urban audiences.

The company offers three cinema models to cater to various markets:

• Express – Designed for quick setup and high footfall locations.

• Signature – Premium experience with enhanced comfort and ambience.

• Luxuriance – Ultra-luxury model for high-end audiences.

Its expansion strategy ensures a balanced presence in metro cities and smaller towns, targeting diverse audience segments.

IPO Structure and Timeline

The Connplex Cinemas IPO is a Book Built Issue amounting to ₹90.27 crore, consisting entirely of a fresh issue of 51 lakh equity shares.

• Subscription opens: August 07, 2025

• Subscription closes: August 11, 2025

• Allotment date: August 12, 2025 (tentative)

• Listing date: August 14, 2025 (tentative)

• Stock exchange: NSE SME

Price Band: ₹168 to ₹177 per share
Market Capitalisation at upper band: ₹338.07 crore
Lot Size: 800 shares per lot
Minimum Investment for Retail Investors: 2 lots = 1,600 shares = ₹2,83,200

Lead Manager: Beeline Capital Advisors Private Limited
Registrar: MUFG Intime India Private Limited
Market Maker: Spread X Securities Private Limited

Grey Market Premium (GMP)

The Grey Market Premium for Connplex Cinemas IPO is currently around ₹28. This suggests a potential listing gain of about 15.81%, although GMP is an informal indicator and can change depending on demand and supply. GMP trading is unofficial and not regulated, so it should only be used for educational purposes.

Company Financial Performance

Connplex Cinemas has shown strong revenue growth over the past three fiscal years:

This shows a remarkable CAGR in revenues and profits, indicating strong scalability in its business model.

Key Performance Indicators

• Pre-Issue EPS (FY24): ₹13.58

• Post-Issue EPS (FY24): ₹9.95

• Pre-Issue P/E Ratio: 13.03x

• Post-Issue P/E Ratio: 17.78x

• ROCE (FY24): 98.25%

• ROE (FY24): 127.28%

• RoNW: 77.78%

These metrics indicate that the IPO is fairly priced compared to the industry P/E of 25.40x, but the stock may already be factoring in much of its growth potential.

Management Strength

The company is led by Mr. Anish Tulshibhai Patel (Managing Director) and Mr. Rahul Kamleshbhai Dhyani (Joint Managing Director), each with over six years of industry experience. Their leadership has shaped Connplex’s strategic expansion, technology integration, and franchise-driven growth model.

Expert Review and Recommendation

Given the high revenue growth, strong profitability, and decent GMP, Connplex Cinemas IPO may deliver short-term listing gains. However, due to the premium valuation and high minimum investment amount, analysts recommend it only for investors with a higher risk appetite.

Verdict: Apply only if you are a risk-tolerant investor aiming for listing gains, not long-term holding at this stage.

Disclaimer
This article is for educational and informational purposes only and does not constitute financial advice. Investment decisions should be based on individual risk tolerance and consultation with SEBI-registered advisors. Market conditions are volatile and subject to change. Neither the author nor the platform is responsible for losses arising from use of this information.

The Upcoming IPOs in this week and coming weeks are Regaal Resources, Mahendra Realtors and Infrastructure, Bluestone Jewellery and Lifestyle, Icodex Publishing Solutions.

The Current active IPO are Star Imaging and Path Lab, Medistep Healthcare, ANB Metal Cast, ConnPlex Cinemas, ALL Time Plastics, JSW Cement, Sawaliya Foods Products.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.